Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06276361
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-02-16
Brief Title:
Pharmacokinetics Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone QUAR in Patients With Schizophrenia
Sponsor:
Rovi Pharmaceuticals Laboratories
Organization:
Rovi Pharmaceuticals Laboratories
Organization Data
Organization:
Rovi Pharmaceuticals Laboratories
Class:
INDUSTRY
Study ID:
ROV-QUAR-2023-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rovi Pharmaceuticals Laboratories
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None